Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Feb 21, 2019
Director
Director Open market or private sale of non-derivative or derivative security 5,500 $11.63
Feb 21, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,500 --
Feb 21, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,500 $5.05
Feb 18, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Feb 18, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Feb 18, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Feb 18, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Feb 18, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Feb 18, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --
Feb 18, 2019
EVP, COO & CCO
EVP, COO & CCO Grant, award or other acquisition pursuant to Rule 16b-3(d) 125,000 --
Feb 18, 2019
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Feb 18, 2019
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 2,285 $11.47
Feb 18, 2019
EVP, COO & CCO
EVP, COO & CCO Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Feb 18, 2019
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 200,000 --
Feb 18, 2019
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Feb 07, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Open market or private sale of non-derivative or derivative security 2,496 $11.03
Feb 07, 2019
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --
Jan 24, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,700 --
Jan 24, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,700 $5.05
Jan 24, 2019
Director
Director Open market or private sale of non-derivative or derivative security 5,700 $10.37
Jan 24, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,550 $3.92
Jan 24, 2019
Director
Director Open market or private sale of non-derivative or derivative security 1,550 $10.37
Jan 24, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,550 --
Jan 22, 2019
Director
Director Open market or private sale of non-derivative or derivative security 6,010 $10.62
Jan 16, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.